Growth Metrics

Novavax (NVAX) Goodwill (2016 - 2025)

Historic Goodwill for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $113.1 million.

  • Novavax's Goodwill fell 1079.63% to $113.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.1 million, marking a year-over-year decrease of 1079.63%. This contributed to the annual value of $107.5 million for FY2024, which is 1567.31% down from last year.
  • As of Q3 2025, Novavax's Goodwill stood at $113.1 million, which was down 1079.63% from $113.0 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Goodwill registered a high of $134.3 million during Q2 2021, and its lowest value of $107.5 million during Q4 2024.
  • In the last 5 years, Novavax's Goodwill had a median value of $126.3 million in 2022 and averaged $123.9 million.
  • As far as peak fluctuations go, Novavax's Goodwill skyrocketed by 16182.08% in 2021, and later plummeted by 1567.31% in 2024.
  • Over the past 5 years, Novavax's Goodwill (Quarter) stood at $131.5 million in 2021, then decreased by 3.92% to $126.3 million in 2022, then increased by 0.89% to $127.5 million in 2023, then dropped by 15.67% to $107.5 million in 2024, then rose by 5.21% to $113.1 million in 2025.
  • Its Goodwill stands at $113.1 million for Q3 2025, versus $113.0 million for Q2 2025 and $112.0 million for Q1 2025.